Invivyd Newsroom

Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Maintains Target Price $3.55

Futu NewsNov 20 22:31

Invivyd Price Target Cut to $10.00/Share From $15.00 by HC Wainwright & Co.

Dow JonesNov 20 20:05

Invivyd Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 20 20:05

Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Cuts Target Price to $3.55

Futu NewsNov 20 19:32

Invivyd's Resilient Strategy and Prospective Growth: Buy Rating Affirmed Amidst Pemgarda Setbacks and New Antibody Developments

TipRanksNov 20 19:18

D. Boral Capital Maintains Buy on Invivyd, Maintains $9 Price Target

BenzingaNov 15 06:06

Invivyd Analyst Ratings

BenzingaNov 15 06:05

Invivyd Initiated at Buy by EF Hutton

Dow JonesOct 30 21:14

EF Hutton Initiates Coverage On Invivyd With Buy Rating, Announces Price Target of $9

BenzingaOct 30 21:03

Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Maintains Target Price $9.5

Futu NewsOct 30 06:31

Invivyd Analyst Ratings

BenzingaOct 30 01:32

HC Wainwright & Co. Reiterates Buy on Invivyd, Maintains $15 Price Target

BenzingaOct 30 01:32

Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Maintains Target Price $9.5

Futu NewsSep 24 19:31

Buy Rating Affirmed for Invivyd: Strong Product Performance and Strategic Market Initiatives

TipRanksSep 9 18:31

Buy Rating on Invivyd Backed by Strong Phase 3 Data and Market Catalysts

TipRanksAug 28 18:31

Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Maintains Target Price $9.5

Futu NewsAug 28 18:31

Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (OtherTLPPF) and Invivyd (IVVD)

TipRanksAug 28 15:48

Invivyd Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow JonesAug 28 00:47

HC Wainwright & Co. Reiterates Buy on Invivyd, Maintains $15 Price Target

BenzingaAug 28 00:37

Invivyd Analyst Ratings

BenzingaAug 28 00:37